Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAN021 in Mild-to-Moderate Plaque Psoriasis
NCT03000608Phase 2Completed
- Sponsor
- Santalis Pharmaceuticals, Inc.
- Start
- May 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of east indian sandalwood oil in plaque psoriasis, sponsored by Santalis Pharmaceuticals, Inc.. Started May 2017; status: completed.
02
Drugs
east indian sandalwood oil
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03000608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03000608.